EVIDENCE SUPPORTING THE SUPERIORITY OF INTRAPERITONEAL CISPLATIN COMPARED TO INTRAPERITONEAL CARBOPLATIN FOR SALVAGE THERAPY OF SMALL-VOLUME RESIDUAL OVARIAN-CANCER

MARKMAN M REICHMAN B HAKES T RUBIN S LEWIS JL JONES W BARAKAT R CURTIN J ALMADRONES L HOSKINS W

M. Markman et al., EVIDENCE SUPPORTING THE SUPERIORITY OF INTRAPERITONEAL CISPLATIN COMPARED TO INTRAPERITONEAL CARBOPLATIN FOR SALVAGE THERAPY OF SMALL-VOLUME RESIDUAL OVARIAN-CANCER, Gynecologic oncology, 50(1), 1993, pp. 100-104

20

Oncology,"Obsetric & Gynecology

Gynecologic oncology → ACNP

00908258

50

1

1993

100 - 104

ISI

0090-8258(1993)50:1<100:ESTSOI>2.0.ZU;2-P